Insurers Warn Aesthetic Practitioners of Multi-Million Pound Lawsuits As a Result of AI

For aesthetic clinics, the legal risk around a treatment complaint is no longer confined to a poor outcome, a difficult consultation or a missing signature on a consent form. The pressure is widening. Patients are arriving better armed, faster to escalate and more able to package dissatisfaction into a polished complaint. At the same time, many clinics are operating through looser care models, with separate prescribers, visiting injectors, device operators, remote consultations and outsourced follow-up. That combination is creating exactly the sort of liability picture insurers do not like.

Specialist brokers are warning that private practitioners are increasingly exposed to large negligence actions as AI-assisted complaints become easier to produce and more persuasive, and as fragmented working patterns make it harder to defend who knew what, when, and why a decision was made. Kevin Culliney, CEO of Whetstone, puts it bluntly: “Patients are increasingly using ChatGPT to compose complaints and initial claims. They might be unhappy about paying for treatment they had expected the NHS to pick up, making them more predisposed to look for ways to get all or some of their money back, and there’s no shortage of law firms happy help them.”

That warning lands at a moment when the broader claims environment is already expensive. NHS Resolution says it received 14,428 new clinical negligence claims and reported incidents in 2024/25, and paid out £3.1 billion in compensation and associated costs across its clinical schemes, up from £2.8 billion in 2023/24. Its provision for future liabilities stood at £60.3 billion as of 31 March 2025. Those are NHS figures, not aesthetics-specific figures, but they show the direction of travel in medical negligence more broadly, especially around the value and complexity of claims.

In aesthetics, the same inflationary pressure is visible on a smaller but still significant scale. Hamilton Fraser reported that from January 2020 to November 2024 it handled 1,096 medical malpractice claims in aesthetics, with dermal fillers, laser and botulinum toxin making up the three most common treatment categories. It also noted that legal costs are increasingly swallowing a large share of the overall claim value, with defence costs for both sides often exceeding half of the total. That matters for clinics because a case does not need to become a blockbuster award to become commercially painful. A mid-value dispute with extensive expert evidence, poor records and multiple defendants can still drain management time, reputation and cash.

The AI point is easy to dismiss as a headline device, but the research base suggests it should be taken seriously. A 2024 JMIR study comparing responses to patient complaints found that GPT-4 replies were preferred by most respondents and scored higher than human-written responses for appropriateness, empathy, quality and satisfaction. In practical terms, that means a patient with a vague sense that something went wrong can now generate a complaint letter that sounds structured, confident and emotionally credible in minutes. A complaint that once might have been a disorganised email can now read like a pre-action document.

At the same time, there is good reason for clinics to be cautious about using AI on their own side of the interaction. The GMC says doctors remain responsible for the decisions they take when using AI and other innovative technologies, and that they should discuss uncertainties and limitations with patients so consent remains informed. The regulator also expects adverse incidents involving software, digital tools and AI-enabled technologies to be reported where patient safety is at risk. In other words, AI does not dilute professional responsibility. It can support workflow, but it does not absorb liability.

That becomes especially important in aesthetics, where many disputes are built around communication, expectations and continuity rather than a single dramatic clinical event. A patient may be assessed by one person, prescribed by another, treated by a third and reviewed by nobody until a problem appears on WhatsApp at 10pm. By then, the notes may be thin, the prescriber may not have seen the patient face to face, batch numbers may be missing, and the original discussion about risks may exist only in memory. Save Face said in late 2025 that complaints relating to botulinum toxin had risen by more than 350% over five years, and that in most of those complaints patients were unaware the product was prescription-only, had been treated by a non-healthcare practitioner, had no face-to-face consultation with a licensed prescriber and did not know what product had actually been used. It also said at least a third of complaints were believed to involve unlicensed or counterfeit toxin.

Government policy is moving in the same direction, which tells its own story about risk. In August 2025, the Department of Health and Social Care confirmed plans for a licensing regime for non-surgical cosmetic procedures in England, following more than 11,800 consultation responses. The government said the changes were prompted by incidents involving little or no medical training, with dangerous complications, permanent scarring and even death. A risk-based framework is now central to the reform. For reputable clinics, that should be read as a commercial warning as much as a regulatory one. Once licensing standards tighten, any practice that still relies on casual documentation, weak prescribing governance or unclear lines of responsibility will look more exposed, not less.

There is also the reputational effect of public claims. In 2025, a widely reported High Court case involved a former YouTuber seeking £1.7 million from a Harley Street surgeon over breast implant treatment she said left her disfigured and ended her career. The surgeon denied wrongdoing, but the value of the claim alone shows how quickly cosmetic treatment disputes can move beyond refund territory into loss of earnings, psychiatric injury and long-term damage arguments. That is precisely why insurers are watching aesthetics more closely.

The other side of the AI story is that patients are also using these tools for health advice before and after treatment, which may shape the complaints clinics receive. A February 2026 Oxford-led study found that people using large language models for medical scenarios did no better than those relying on traditional methods such as online search or their own judgement, and often struggled to identify what information the model needed to give safe advice. For aesthetic practitioners, that means post-treatment confusion may become harder to untangle. Patients may present convinced by flawed chatbot guidance, or arrive with generated language that sounds medically certain even when the underlying advice is weak.

Culliney also points to the insurance structure itself. “Discretionary mutual membership (not insurance),” he says, “is one of the biggest problems facing the medical sector today,” particularly when clinicians only discover its limitations once a serious claim lands. In aesthetics, where businesses often combine medical and beauty services under one brand, that issue deserves attention. A clinic may assume everyone on site is covered, only to discover after an incident that cover was individual, conditional, treatment-specific or dependent on facts that were never properly recorded.

For clinic owners and senior practitioners, the takeaway is complaints are becoming more coherent, claimant expectations are rising, and longstanding gaps in aesthetics practice are becoming easier to spot. Stronger notes, better consent, real follow-up, face-to-face prescribing where required, clear product traceability and defensible supervision are no longer just markers of good practice. They are the difference between a complaint that can be resolved quickly and one that develops into a multi-party negligence claim with serious financial consequences. In a market where patients can generate a solicitor-style narrative in minutes, clinics need records, governance and communication that can stand up to far closer scrutiny.